{"transactions":[{"id":771441,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:08.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":93949,"source":{"system":"sec-edgar","filing":"0001193125-26-231464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000119312526231464/ownership.xml","form_type":"4"}},{"id":1138770,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:09.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,861 restricted stock units."}],"balance_after":63949,"source":{"system":"sec-edgar","filing":"0000950170-25-075891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000095017025075891/ownership.xml","form_type":"4"}},{"id":1363403,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-15T14:00:20.000Z","date":"2024-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19861,"price":71,"value":1410131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of the reporting person's shares of the Issuer's common stock, upon the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 8, 2024 (the \"Merger Agreement\"), among the Issuer, Boston Scientific Corporation (\"Parent\") and Sadie Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger of Merger Sub with and into the Issuer with the Issuer as the surviving corporation (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective time\"), each outstanding share of the Issuer's common stock was canceled and converted automatically into the right to receive $71.00 in cash, without interest (The \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of the reporting person's shares of the Issuer's common stock, upon the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 8, 2024 (the \"Merger Agreement\"), among the Issuer, Boston Scientific Corporation (\"Parent\") and Sadie Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger of Merger Sub with and into the Issuer with the Issuer as the surviving corporation (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective time\"), each outstanding share of the Issuer's common stock was canceled and converted automatically into the right to receive $71.00 in cash, without interest (The \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-007712","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218024007712/primarydocument.xml","form_type":"4"}},{"id":1505178,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T21:30:21.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":33260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":33260,"derivative":{"exercise_price":4.97,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":33260},"source":{"system":"sec-edgar","filing":"0000950170-24-063616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000095017024063616/ownership.xml","form_type":"4"}},{"id":1505177,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T21:30:21.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,788 restricted stock units."}],"balance_after":40032,"source":{"system":"sec-edgar","filing":"0000950170-24-063616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000095017024063616/ownership.xml","form_type":"4"}},{"id":1517089,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T22:20:09.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":19356,"price":5.1664,"value":100000.8384,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1490 to $5.1698 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,585 restricted stock units"}],"balance_after":24941,"source":{"system":"sec-edgar","filing":"0000950170-24-059856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000095017024059856/ownership.xml","form_type":"4"}},{"id":1842560,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-29T00:21:48.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19861,"source":{"system":"sec-edgar","filing":"0001562180-23-005533","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218023005533/primarydocument.xml","form_type":"4"}},{"id":1877749,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T01:00:23.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":6305,"derivative":{"exercise_price":26.34,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":6305},"source":{"system":"sec-edgar","filing":"0001209191-23-032350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000120919123032350/doc4.xml","form_type":"4"}},{"id":1877748,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T01:00:23.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":2753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.  The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,585 RSUs."}],"balance_after":5585,"source":{"system":"sec-edgar","filing":"0001209191-23-032350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000120919123032350/doc4.xml","form_type":"4"}},{"id":2143831,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T23:00:15.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":19439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2022 such that the stock option will be fully vested and exercisable on October 1, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2022 such that the stock option will be fully vested and exercisable on October 1, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":19439,"derivative":{"exercise_price":22.07,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":19439},"source":{"system":"sec-edgar","filing":"0001209191-22-052526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000120919122052526/doc4.xml","form_type":"4"}},{"id":2143830,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T23:00:15.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":2832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting October 1,  2023 such that the RSUs will be fully vested on October 1, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":2832,"source":{"system":"sec-edgar","filing":"0001209191-22-052526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000120919122052526/doc4.xml","form_type":"4"}},{"id":2176763,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T00:14:04.000Z","date":"2022-08-18","kind":"grant","acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16861,"source":{"system":"sec-edgar","filing":"0001562180-22-006265","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022006265/primarydocument.xml","form_type":"4"}},{"id":2210588,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-07-08T00:20:31.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest in full on April 8, 2020."}],"balance_after":0,"derivative":{"exercise_price":21.04,"expiration_date":"2029-04-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2210587,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-07-08T00:20:31.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in full on August 22, 2020."}],"balance_after":0,"derivative":{"exercise_price":34.1,"expiration_date":"2029-08-22","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2210586,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-08T00:20:31.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":5250,"price":60,"value":315000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":14761,"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2210585,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-08T00:20:31.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":1750,"price":62.71,"value":109742.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":20011,"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2210584,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-08T00:20:31.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":4167,"price":34.1,"value":142094.7,"ownership":{"direct":true},"balance_after":21761,"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2210583,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-08T00:20:31.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":10000,"price":21.04,"value":210400.0,"ownership":{"direct":true},"balance_after":17594,"source":{"system":"sec-edgar","filing":"0001562180-22-005626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022005626/primarydocument.xml","form_type":"4"}},{"id":2312610,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T00:04:19.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":1750,"price":61.4897,"value":107606.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $61.46 to $61.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7594,"source":{"system":"sec-edgar","filing":"0001562180-22-003044","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022003044/primarydocument.xml","form_type":"4"}},{"id":2312609,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T00:04:19.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":3500,"price":60,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":9344,"source":{"system":"sec-edgar","filing":"0001562180-22-003044","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218022003044/primarydocument.xml","form_type":"4"}},{"id":2528344,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T01:15:52.000Z","date":"2021-10-22","kind":"grant","acquired":true,"shares":2261,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12844,"source":{"system":"sec-edgar","filing":"0001562180-21-006776","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218021006776/primarydocument.xml","form_type":"4"}},{"id":3046129,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-27T00:18:12.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10583,"source":{"system":"sec-edgar","filing":"0001562180-20-005681","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218020005681/primarydocument.xml","form_type":"4"}},{"id":3203330,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-03-18T16:32:31.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":103847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amount reflects the grant of restricted stock units to the reporting person in connection with her appointment to the board of directors.  The restricted stock units will vest as to 25% of the underlying shares of common stock on each anniversary of the grant date such that all of the shares will vest on the fourth anniversary of the grant date."}],"balance_after":103847,"source":{"system":"sec-edgar","filing":"0001013606-20-000043","document":"wf-form4_158456353349604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000043/wf-form4_158456353349604.xml","form_type":"4"}},{"id":3429055,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-26T22:58:50.000Z","date":"2019-08-22","kind":"grant","acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on August 18, 2020."}],"balance_after":4167,"derivative":{"exercise_price":34.1,"expiration_date":"2029-08-22","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001562180-19-004491","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218019004491/primarydocument.xml","form_type":"4"}},{"id":3429054,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-26T22:58:50.000Z","date":"2019-08-22","kind":"grant","acquired":true,"shares":2083,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7083,"source":{"system":"sec-edgar","filing":"0001562180-19-004491","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000156218019004491/primarydocument.xml","form_type":"4"}},{"id":3559151,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-10T01:15:32.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in full on April 8, 2020, provided the reporting person remains in continuous service through such date."}],"balance_after":10000,"derivative":{"exercise_price":21.04,"expiration_date":"2029-04-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-010422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000089924319010422/doc4.xml","form_type":"4"}},{"id":3559150,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":45938,"kind":"person","name":"Kiernan Jane E","position":1,"cik":"0001379171","reported_name":"Kiernan Jane E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T01:15:32.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-19-010422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379171/000089924319010422/doc4.xml","form_type":"4"}}]}